Literature DB >> 21907301

COX-2 and PGE2-dependent immunomodulation in breast cancer.

Edward P Chen1, Emer M Smyth.   

Abstract

COX-derived prostanoids play multiple roles in inflammation and cancer. This review highlights research examining COX-2 and PGE(2)-dependent regulation of immune cell polarization and function within the tumor microenvironment, particularly as it pertains to breast cancer. Appreciating PGE(2)-mediated immunomodulation is important in understanding how tumors evade immune surveillance by re-educating infiltrating inflammatory and immune cells to support tumorigenesis. Elucidation of the multiple and complex influences exerted by tumor stromal components may lead to targeted therapies in breast and other cancers that restrain microenvironmental permissiveness and maintain natural defenses against malignancies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907301      PMCID: PMC4031099          DOI: 10.1016/j.prostaglandins.2011.08.005

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  86 in total

Review 1.  The role of cyclooxygenase-2 in breast cancer: review.

Authors:  Gurpreet Singh-Ranger; Mohamed Salhab; Kefah Mokbel
Journal:  Breast Cancer Res Treat       Date:  2007-07-12       Impact factor: 4.872

Review 2.  Inflammatory cell infiltration of tumors: Jekyll or Hyde.

Authors:  James E Talmadge; Moses Donkor; Eric Scholar
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 3.  Microenvironmental regulation of cancer development.

Authors:  Min Hu; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2008-02-20       Impact factor: 5.578

4.  Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.

Authors:  Junko Yokokawa; Vittore Cereda; Cinzia Remondo; James L Gulley; Philip M Arlen; Jeffrey Schlom; Kwong Y Tsang
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

5.  Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.

Authors:  Yongliang Zhang; Qiuyan Liu; Minggang Zhang; Yizhi Yu; Xia Liu; Xuetao Cao
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

6.  Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner.

Authors:  Sheraz Yaqub; Karen Henjum; Milada Mahic; Frode L Jahnsen; Einar M Aandahl; Bjørn A Bjørnbeth; Kjetil Taskén
Journal:  Cancer Immunol Immunother       Date:  2007-10-26       Impact factor: 6.968

Review 7.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

Review 8.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

9.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

Review 10.  Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.

Authors:  Louise R Howe
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  41 in total

1.  Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.

Authors:  Min Zhang; Hai Zhang; Shanyu Cheng; Dengcai Zhang; Yan Xu; Xiaoming Bai; Shukai Xia; Li Zhang; Juan Ma; Mingzhan Du; Yipin Wang; Jie Wang; Meng Chen; Jing Leng
Journal:  Tumour Biol       Date:  2014-04-24

Review 2.  Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.

Authors:  Victoria Wu; Huwate Yeerna; Nijiro Nohata; Joshua Chiou; Olivier Harismendy; Francesco Raimondi; Asuka Inoue; Robert B Russell; Pablo Tamayo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 3.  Multifaceted roles of PGE2 in inflammation and cancer.

Authors:  Masako Nakanishi; Daniel W Rosenberg
Journal:  Semin Immunopathol       Date:  2012-09-21       Impact factor: 9.623

4.  Cancer pain physiology.

Authors:  Sarah Falk; Kirsty Bannister; Anthony H Dickenson
Journal:  Br J Pain       Date:  2014-11

Review 5.  Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Authors:  Jaime Fornetti; Holly A Martinson; Courtney B Betts; Traci R Lyons; Sonali Jindal; Qiuchen Guo; Lisa M Coussens; Virginia F Borges; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-22       Impact factor: 2.673

6.  Impact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patients.

Authors:  Can Atalay
Journal:  Ulus Cerrahi Derg       Date:  2015-06-01

7.  Targeting Akt3 signaling in triple-negative breast cancer.

Authors:  Y Rebecca Chin; Taku Yoshida; Andriy Marusyk; Andrew H Beck; Kornelia Polyak; Alex Toker
Journal:  Cancer Res       Date:  2013-12-12       Impact factor: 12.701

8.  Breaking barriers for T cells by targeting the EPHA2/TGF-β/COX-2 axis in pancreatic cancer.

Authors:  Jose R Conejo-Garcia
Journal:  J Clin Invest       Date:  2019-07-29       Impact factor: 14.808

Review 9.  Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.

Authors:  Zora Djuric
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

10.  COX-1-derived thromboxane A2 plays an essential role in early B-cell development via regulation of JAK/STAT5 signaling in mouse.

Authors:  Qiong Yang; Maohua Shi; Yujun Shen; Yingjiao Cao; Shengkai Zuo; Caojian Zuo; Hui Zhang; Dmitry I Gabrilovich; Ying Yu; Jie Zhou
Journal:  Blood       Date:  2014-07-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.